Cognitive Bias Modification for Obsessive-Compulsive Disorder
What You Need to Know Before You Apply
What is the purpose of this trial?
This study will conduct a randomized controlled trial of Cognitive Bias Modification for Interpretation (CBM-I) as an augmentation to treatment as usual for obsessive compulsive disorder (OCD). CBM-I is a digital intervention designed to directly manipulate interpretation bias through repeated practice on a training task, thereby inducing cognitive changes in a relatively automatic or implicit manner. Specifically, this study will examine the feasibility, acceptability, and clinical outcomes associated with CBM-I.Adults with obsessive compulsive disorder (OCD) will be recruited from a treatment program for this disorder and participants will be randomly assigned to either receive: 1) up to 12 sessions of CBM-I, or or up to 12 sessions of psychoeducation as a control condition.
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications. It seems likely that you can continue your usual treatment, as the study is an addition to standard OCD treatment.
Is Cognitive Bias Modification safe for humans?
How is Psychoeducation different from other treatments for OCD?
Psychoeducation for OCD is unique because it focuses on educating patients about their condition and treatment options, which can empower them to manage their symptoms more effectively. Unlike traditional therapies that may involve direct exposure to fears, psychoeducation provides knowledge and understanding, which can be a less intimidating approach for some patients.23567
What data supports the effectiveness of the treatment Cognitive Bias Modification for Obsessive-Compulsive Disorder?
Are You a Good Fit for This Trial?
This trial is for adults over 18 with a primary diagnosis of OCD, confirmed by specific clinical assessments. Participants must be able to complete computer tasks and consent to the main study protocol. Those with acute psychosis or a psychotic disorder cannot join.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants receive up to 12 sessions of Cognitive Bias Modification for Interpretation (CBM-I) or psychoeducation as a control condition
Follow-up
Participants are monitored for safety and effectiveness after treatment
What Are the Treatments Tested in This Trial?
Interventions
- Cognitive bias modification for interpretation bias
- Psychoeducation
Find a Clinic Near You
Who Is Running the Clinical Trial?
Mclean Hospital
Lead Sponsor